is still helping CureVac make COVID-19 vaccines and could expand its capacity to assist other vaccine manufacturers as well, finance chief Harry Kirsch told…
Swiss drugmaker Novartis has signed a deal to make ingredients for Roche's Actemra remedy that's being repurposed for individuals with COVID-19, the corporate…
